Mature B-cell malignancies
Clinical trials for Mature B-cell malignancies explained in plain language.
Never miss a new study
Get alerted when new Mature B-cell malignancies trials appear
Sign up with your email to follow new studies for Mature B-cell malignancies, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for tough blood cancers in early trial
Disease control CompletedThis early-stage study tests a new drug, BGB-11417, in 64 adults with B-cell blood cancers that have come back or not responded to prior treatments. The main goals are to find the safest dose and understand side effects. Researchers will also look for signs that the drug shrinks …
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase 1 • Sponsor: BeiGene • Aim: Disease control
Last updated Sep 22, 2026 03:00 UTC
-
New targeted pill shows promise for japanese blood cancer patients
Disease control CompletedThis study tested a drug called zanubrutinib in 55 Japanese patients with B-cell blood cancers that had come back or not responded to prior treatment. The goal was to check safety and how well the drug works. Zanubrutinib is taken as a pill twice daily and targets a protein that …
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase 1/2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC